Related Experiment Videos
[Relation between corpus luteum function and serum prolactin concentration in early pregnancy]
Zentralblatt Fur Gynakologie
|January 1, 1986
Summary
Bromocriptine effectively lowered serum prolactin in early pregnancy. This intervention did not impact corpus luteum function, as indicated by progesterone and estradiol levels.
Area of Science:
- Reproductive Endocrinology
- Pharmacology
Context:
- Early pregnancy (6-8 weeks) is a critical period for hormonal regulation.
- Serum prolactin levels can be elevated during early pregnancy.
- Corpus luteum function is vital for maintaining early pregnancy.
Purpose:
- To investigate the effect of a single bromocriptine dose on serum prolactin concentrations in early pregnancy.
- To assess the impact of bromocriptine-induced prolactin reduction on corpus luteum steroidogenesis (progesterone and estradiol secretion).
Summary:
- A single dose of bromocriptine successfully reduced serum prolactin concentrations in 20 patients during the 6th-8th week of pregnancy.
- Serum levels of progesterone and estradiol were monitored to evaluate corpus luteum function.
- No significant changes in corpus luteum function were observed in relation to prolactin levels after bromocriptine administration.
Impact:
- This study suggests that bromocriptine can be used to manage hyperprolactinemia in early pregnancy without compromising essential corpus luteum function.
- Findings provide evidence for the safety of bromocriptine in early gestation regarding luteal phase support.
- Further research may explore long-term effects and optimal dosing strategies for bromocriptine in pregnancy.